About the Corporate Partnership Programme

The Corporate Partnership Programme brings together non-industry and key IAS industry partners to drive important conversations across the HIV continuum of care.

In 2021, it expanded from the flagship Industry Liaison Forum to bring two additional groups under its umbrella – the Towards an HIV Cure: Industry Collaboration Group and the HIV Vaccine Industry Partnership Group. The expansion strengthens collaboration around specific pressing needs in the HIV response.

The Industry Liaison Forum convenes biomedical industry and non-industry stakeholders, including community-based organizations, on a broad range of topics relevant for the strong response of the pharmaceutical, diagnostics and other industry sectors to HIV.

The Towards an HIV Cure: Industry Collaboration Group aims to identify and prioritize ways for biomedical industry and non-industry stakeholders to work together in HIV cure research and development.

The HIV Vaccine Industry Partnership Group brings together the biomedical industry and non-industry stakeholders to address the complexities of HIV vaccine research and development.

Each group offers stakeholders opportunities to inform research agendas; explore (faster) ways to get new technologies to markets; and mobilize the biomedical industry and non-industry (academic, civil society and global health institutions) towards meeting the groups’ goals.

Visit our individual pages to find concrete case studies that show how membership could work for you:

Join the Corporate Partnership Programme now

Joining the Corporate Partnership Programme (CPP) places you at the forefront of global HIV research, innovation and collaboration. Here are some benefits of joining:

• Prominent brand visibility

  • Enhance your brand’s visibility on IAS+ and the CPP webpage and in relevant publications.

  • Be recognized at IAS events and conferences.

• Networking and engagement

  • Connect and engage with leaders in the biomedical industry, community-based organizations, academic institutions, civil society and global health institutions.

  • Participate in thematic roundtables and quarterly calls.

  • Join exclusive networking events and meetings at the International AIDS Conference, IAS Conference on HIV Science and HIV Research for Prevention Conference.

• Influence and collaboration

  • Shape the future of HIV care by engaging with stakeholders to drive important conversations across the continuum of care.

  • Contribute to and propose topics and agenda items for CPP activities.

  • Inform research agendas and explore faster pathways to market for new technologies. 

  • Collaborate in a vibrant and productive environment to advance new ideas and solutions.

• Direct access to IAS leadership

  • Meet members of the IAS Governing Council at the International AIDS Conference and the IAS Conference on HIV Science.

Corporate Partnership Programme partners

The IAS would like to thank its 2023 Corporate Partners: